NDC 13668-462

anagrelide

Anagrelide

anagrelide is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is Anagrelide Hydrochloride.

Product ID13668-462_8a2d4098-44e4-4eff-96b6-336cf7081c81
NDC13668-462
Product TypeHuman Prescription Drug
Proprietary Nameanagrelide
Generic NameAnagrelide
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2017-06-30
Marketing CategoryANDA / ANDA
Application NumberANDA209151
Labeler NameTorrent Pharmaceuticals Limited
Substance NameANAGRELIDE HYDROCHLORIDE
Active Ingredient Strength1 mg/1
Pharm ClassesDecreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 13668-462-01

100 CAPSULE in 1 BOTTLE (13668-462-01)
Marketing Start Date2017-06-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 13668-462-74 [13668046274]

anagrelide CAPSULE
Marketing CategoryANDA
Application NumberANDA209151
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-06-30

NDC 13668-462-30 [13668046230]

anagrelide CAPSULE
Marketing CategoryANDA
Application NumberANDA209151
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-06-30

NDC 13668-462-01 [13668046201]

anagrelide CAPSULE
Marketing CategoryANDA
Application NumberANDA209151
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-06-30

Drug Details

Active Ingredients

IngredientStrength
ANAGRELIDE HYDROCHLORIDE1 mg/1

OpenFDA Data

SPL SET ID:875cc32a-219c-4b6b-802a-98a47cbc9a78
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 597852
  • 597850
  • UPC Code
  • 0313668462012
  • 0313668453010
  • Pharmacological Class

    • Decreased Platelet Production [PE]
    • Platelet-reducing Agent [EPC]
    • Phosphodiesterase 3 Inhibitors [MoA]

    NDC Crossover Matching brand name "anagrelide" or generic name "Anagrelide"

    NDCBrand NameGeneric Name
    13668-453anagrelideanagrelide
    13668-462anagrelideanagrelide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.